Public annual accounts

ALGEMENE BOUWONDERNEMING V & M financials

A multi-period view of the public annual-account figures reported for ALGEMENE BOUWONDERNEMING V & M, with comparable measures and links to available source documents.

Company overview
Registry number

0839048218

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Dec 31, 2025

Financial evidence

2025 versus 2024

Operating line
€1,434,130

+0.5%

EBITDA
€470,968

-12.8%

Total assets
€3,085,219

-3.7%

Equity
€1,026,352

+22.5%

EBITDA margin +32.8% · Equity ratio +33.3%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO
Fiscal year
Gross margin
EBITDA
Total assets
Equity
Filing
202531 Dec 2025€1,434,130€470,968€3,085,219€1,026,352-
202431 Dec 2024€1,426,880€540,196€3,203,754€837,950-
Gross margin as filed under the abbreviated schema. This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report